Cerebral Fluid Flow and Function: Lymphatics, Glymphatics and the Choroid Plexus joint with Brain Therapeutics: Disruptive Technologies and Opportunities Scientific Organizers: Edwin S. Monuki, Maria Lehtinen and Maiken Nedergaard Date: February 16 - 19, 2020
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA The cerebrospinal fluid (CSF) has long been a 'missing link' in our understanding of brain form, function, and disease. However, recent work has begun to illuminate how the CSF regulates the brain in ways that extend far beyond its passive historical roles and provides unique opportunities for studying, diagnosing, and potentially treating brain disorders. This Keystone Symposia conference brings together an interdisciplinary group of new and established scientists to discuss this newfound excitement about CSF. By exchanging discoveries about CSF sources (choroid plexus), routes (glymphatics), drainage (lymphatics), clinical utilities, and by fostering new ideas, collaborations, and training opportunities, this conference aims to coalesce an international community that can propel the CSF field forward. This conference is being held jointly with the Keystone Symposia conference titled Brain Therapeutics: Disruptive Technologies and Opportunities for Drug Development. The goal of this paring is to stimulate thinking about CSF-based medicinal therapies, given the advantages of CSF over blood in being 'behind' the blood-brain barrier and in equilibrating with the interstitial fluid surrounding brain cells. Scholarship Deadline: October 29 2019 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
We gratefully acknowledge the generous grant for this conference provided by: National Institute of Neurological Disorders and Stroke (NINDS)Grant No. 1R13NS115398-01 Funding for this conference was made possible (in part) by 1R13NS115398-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |